For the past two years, the healthcare industry has analyzed, debated, and prepared for CMS’s Interoperability and Prior Authorization Final Rule. Legal teams parsed statutory authority. Compliance leaders mapped regulatory obligations. IT departments evaluated vendor capabilities and API development timelines.
Throughout 2024 and 2025, much of the conversation centered on understanding prior authorization requirements and outlining plans to meet them. In 2026, that preparatory phase has given way to operational reality.
The rule’s key provisions took effect in January, and prior authorization reform has shifted from interpretation to execution. Transparency requirements are active. Standardized decision timelines are in force. Public reporting expectations now carry visibility beyond internal compliance teams. The regulatory structure is largely established, and federal leaders are signaling that prolonged debate is giving way to measurable expectations.
That shift was evident in late February at the American Medical Association’s National Advocacy Conference. CMS Deputy Administrator and Center for Medicare Director Chris Klomp addressed prior authorization directly, stating that he hopes to be “done talking about prior authorization” within “double-digit months.”1
The comment reflects more than frustration with administrative burden. It suggests that CMS expects tangible operational change under the authorities and commitments already in place, rather than prolonged debate over additional regulatory interventions. Klomp acknowledged that CMS has limited additional regulatory authority across Medicare, Medicaid, and commercial markets.1 The framework has been set. The focus now rests on implementation and execution.
Voluntary commitments secured from insurers, including reducing the volume of codes subject to prior authorization, tightening decision timelines, increasing transparency, and working toward a single application programming interface, now face real-world testing. In 2026, those commitments move from public statements to operational proof points. Providers and regulators are evaluating whether day-to-day performance reflects those pledges.
Are Prior Authorization Requirements Making a Difference?
This transition exposes an important distinction between compliance planning and operational credibility. During the planning phase, progress could be demonstrated through policy updates, implementation roadmaps, and vendor contracts.
But with reporting obligations active and timelines standardized, performance is visible. Publicly reported metrics introduce reputational considerations. Denial rationale requirements test whether review processes are clinically grounded and consistently applied. Teams are discovering that policy alignment does not automatically translate into consistent performance and workflow reliability.
Interoperability is central to reform efforts, particularly the development of standardized APIs to support electronic prior authorization. Full API implementation is not required until January 1, 2027, but 2026 has become a critical validation year.
Conversations that once centered on roadmap design and vendor selection are now focused on operational reliability, integration performance, and reputational exposure. API readiness is no longer a future-state initiative; it’s being evaluated based on how consistently it performs in production environments that directly affect providers and members.
At the same time, risks are emerging. Klomp cautioned against a proliferation of portals and APIs that could fragment rather than streamline processes.1 His remarks to physicians showed the importance of choosing systems capable of communicating across payers. The warning means that technological expansion without architectural coordination can reproduce administrative complexity in digital form. Fragmented implementation could result in multiple parallel workflows rather than a unified pathway.
The vision CMS has is ambitious. Klomp stated that the ultimate goal is that there should be no human working on prior authorization.1 That aspiration points toward automated adjudication based on structured clinical data and standardized decision logic operating in the background of care delivery. Achieving that outcome takes more than software deployment. It calls for consistent data capture at the point of care, aligned clinical criteria, integrated system design, and importantly, clear governance structures responsible for oversight and performance monitoring.
Can Automation Solve a Trust Problem?
Klomp described prior authorization as a “wedge” between physicians and payers, one that strained relationships and eroded confidence over decades.1 Physicians often view denials as obstacles that will be overturned upon appeal. Payers often view utilization management as necessary protection against unsustainable cost growth. These assumptions shape behavior on both sides.
Operational performance in 2026 will influence whether that dynamic changes. When decision timelines are met consistently and explanations are specific and clinically grounded, ideally confidence will gradually rebuild. Regulation can standardize processes and require transparency. It can’t mandate trust. Trust develops through repeated, predictable performance.
Healthcare teams are also confronting structural questions about ownership. Prior authorization responsibilities have historically been distributed across utilization management, operations, IT, provider relations, and compliance teams. The new regulatory landscape places greater pressure on organizations to centralize accountability. Without coordinated oversight, variability in turnaround times, denial documentation, and reporting accuracy becomes difficult to manage.
It would be easy to treat 2026 as a transitional year before the 2027 API deadline. But public reporting introduces reputational visibility, and standardized timelines need operational discipline. CMS leadership has signaled that progress should be measurable in the near term. This is the year when infrastructure, governance, and execution practices are tested under real conditions.
If you approach this period solely as a compliance exercise, you’ll find the demands disruptive. Viewing it as an operational modernization effort may help uncover strategic advantages. More reliable authorization processes reduce friction with providers. Transparent decision-making supports stronger network relationships. Streamlined workflows lower administrative cost. Faster determinations contribute to improved member experience. These outcomes extend beyond regulatory adherence and touch core performance metrics.
The healthcare industry has debated prior authorization reform for years. The regulatory architecture is now in place, and public commitments have been made. Federal leadership has indicated that continued discussion without tangible improvement is not sufficient. The path forward must include disciplined operational execution, coordinated technology deployment, and sustained performance improvement.
In 2026, prior authorization reform enters its most consequential phase. Can healthcare organizations translate regulatory intent into durable operational performance that improves cost management, provider experience, and patient care simultaneously?
Turning Regulatory Pressure into Operational Strength
Clearlink helps managed care organizations strengthen prior authorization across both clinical and operational management functions. Our teams support utilization management optimization, workflow redesign, technology selection and implementation, and delegated clinical BPaaS solutions that stabilize processes and improve decision consistency.
By integrating clinical expertise with operational execution, we help health plans reduce administrative friction, support provider relationships, and drive sustainable performance across prior authorization programs.
Connect with Clearlink to discuss how we can support your prior authorization strategy, improve clinical and operational performance, and help your organization move forward with clarity and confidence.
Sources:
1. This CMS Official Is Ready to Be ‘Done Talking’ About Prior Authorization, MedPage Today